| 1 |
Highlights on selected growth factors and their receptors as promising anticancer drug targets |
|
| | Mohammed A. Mansour, Valentina S. Caputo, Eiman Aleem | | | The International Journal of Biochemistry & Cell Biology. 2021; 140: 106087 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
PCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrations |
|
| | Qiuju Dong,Pengfei Yu,Liang Ye,Jianzhao Zhang,Hongbo Wang,Fangxia Zou,Jingwei Tian,Hiroshi Kurihara | | | Scientific Reports. 2019; 9(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
A digital PCR assay development to detect EGFR T790M mutation in NSCLC patients |
|
| | Ruifeng Zhou,Yiran Cai,Zhaoliang Li,Shuangye Shen,Mozhou Sha,Steven R. Head,Yan Wang | | | Frontiers in Laboratory Medicine. 2018; 2(3): 89 | | | [Pubmed] [Google Scholar] [DOI] | |
|
